H1, a NYC-based provider of data driven solutions for the healthcare industry, raised $12.9m in Series A funding.
The round was led Menlo Ventures with participation from Novartis dRx, Y Combinator, Baron Davis Enterprises, ClearPoint Investment Partners, Jeff Hammerbacher, Liquid 2 Ventures, and Underscore VC. In conjunction with the funding, Greg Yap, partner at Menlo Ventures, will join H1’s board of directors.
The company will use the capital to grow its existing team, including sales, customer success and engineering, as well as to accelerate expansion into additional market segments.
Founded in 2017 by CEO Ariel Katz, H1 is a data platform connecting healthcare and life science professionals and companies. Its solution provides comprehensive in-depth profiles of more than 8 million healthcare professionals and 16,000 institutions in 70-plus countries, all of which are kept up-to-date weekly. The company enables users to understand and analyze any healthcare professional’s full profile, including expertise, interests, publications, location, conferences and congresses, and clinical trials, and leverages AI to identify the thought leading doctors in a given disease area.
The company counts over 35 pharmaceutical companies as clients.